NovoCure Ltd. (NVCR)
14.99
-0.21
(-1.38%)
USD |
NASDAQ |
Oct 06, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
NovoCure Max Drawdown (5Y) : 95.55% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 95.55% |
| August 31, 2026 | 95.55% |
| July 31, 2026 | 95.55% |
| June 30, 2026 | 95.55% |
| May 31, 2026 | 95.55% |
| April 30, 2026 | 95.55% |
| March 31, 2026 | 95.55% |
| February 28, 2026 | 95.55% |
| January 31, 2026 | 95.17% |
| December 31, 2025 | 95.17% |
| November 30, 2025 | 95.17% |
| October 31, 2025 | 95.17% |
| September 30, 2025 | 95.17% |
| August 31, 2025 | 95.17% |
| July 31, 2025 | 95.14% |
| June 30, 2025 | 95.07% |
| May 31, 2025 | 95.07% |
| April 30, 2025 | 95.07% |
| March 31, 2025 | 95.07% |
| February 28, 2025 | 95.07% |
| January 31, 2025 | 95.07% |
| December 31, 2024 | 95.07% |
| November 30, 2024 | 95.07% |
| October 31, 2024 | 95.07% |
| September 30, 2024 | 95.07% |
| Date | Value |
|---|---|
| August 31, 2024 | 95.07% |
| July 31, 2024 | 95.07% |
| June 30, 2024 | 95.07% |
| May 31, 2024 | 95.07% |
| April 30, 2024 | 95.07% |
| March 31, 2024 | 95.07% |
| February 29, 2024 | 95.07% |
| January 31, 2024 | 95.07% |
| December 31, 2023 | 95.07% |
| November 30, 2023 | 95.07% |
| October 31, 2023 | 94.40% |
| September 30, 2023 | 92.84% |
| August 31, 2023 | 91.75% |
| July 31, 2023 | 85.53% |
| June 30, 2023 | 82.14% |
| May 31, 2023 | 74.98% |
| April 30, 2023 | 74.98% |
| March 31, 2023 | 74.98% |
| February 28, 2023 | 74.91% |
| January 31, 2023 | 74.91% |
| December 31, 2022 | 74.91% |
| November 30, 2022 | 74.91% |
| October 31, 2022 | 74.91% |
| September 30, 2022 | 74.91% |
| August 31, 2022 | 74.91% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Smith & Nephew plc | 55.07% |
| LivaNova Plc | 68.81% |
| Tristel Plc | 28.81% |
| EKF Diagnostics Holdings Plc | 77.00% |
| Niox Group Plc | 63.91% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -46.45 |
| Beta (5Y) | 0.9886 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 76.57% |
| Historical Sharpe Ratio (5Y) | -0.4775 |
| Historical Sortino (5Y) | -1.018 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.12% |